ARES vs IVZ
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
ARES
64.6
AI Score
VS
IVZ Wins
IVZ
68.9
AI Score
Investment Advisor Scores
IVZ
69score
Recommendation
BUY
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | ARES | IVZ | Winner |
|---|---|---|---|
| Revenue | 2.59B | 3.57B | IVZ |
| Net Income | 293.22M | 558.00M | IVZ |
| Net Margin | 11.3% | 15.6% | IVZ |
| ROE | 7.4% | 4.5% | ARES |
| ROA | 1.0% | 2.0% | IVZ |
| Total Assets | 29.63B | 27.47B | ARES |
Relative Price Performance (Last 90 Days)
ARES 1M: +1.8%
· 3M: -2.2%
IVZ 1M: -6.3%
· 3M: -3.8%
Current Technical Phase
ARES
NeutralHold
Mixed signals - no dominant trend phase, RSI 57
IVZ
MarkdownSell / avoid
Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 41
Fundamentals Snapshot
| Metric | ARES | IVZ |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 17.4 | 8.8 |
| Trailing P/E | 53.9 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.2% |
| Gross Margin | 1.0% | 0.3% |
| Operating Margin | 0.1% | 0.2% |
| EPS | 2.17 | -0.68 |
| Dividend Yield | 0.04% | 0.03% |
Frequently Asked Questions
Based on our detailed analysis, IVZ is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.